T
ACAD icon

TradeWorx’s Acadia Pharmaceuticals ACAD Stock Holding History

TradeWorx’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-12,139
Closed -$333K – 472
2013
Q3 		$333K Sell
12,139
-18,754
-61% -$392K 0.15% 242
2013
Q2 		$561K Buy
+30,893
New +$426K 0.24% 127

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TradeWorx's ACAD Position: Q4 2013 in Review

TradeWorx sold out of Acadia Pharmaceuticals (ACAD) in Q4 2013, closing a stake of 12,139 shares — an estimated $333K sold.

TradeWorx first reported a position in ACAD in Q2 2013 and held it in 2 quarters. The position peaked at $561K in Q2 2013. 155 funds tracked by Wall St. Rank hold ACAD as of Q4 2013.

  • TradeWorx reported no remaining Acadia Pharmaceuticals position as of Q4 2013 after selling out during the quarter.
  • TradeWorx sold 12,139 Acadia Pharmaceuticals shares in Q4 2013, an estimated $333K.
  • TradeWorx first reported a position in Acadia Pharmaceuticals in Q2 2013 and held it in 2 quarters.
  • TradeWorx's Acadia Pharmaceuticals position peaked at $561K in Q2 2013.
  • 155 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q4 2013.

Based on TradeWorx's 13F filing for Q4 2013, filed 18 Feb 2014.